1033600-97-3

Upstream product

• 1033602-72-0 ethyl 2-(3-cyano-4-hydroxyphenyl)nicotinate hydrochloride 
• 74-88-4 methyl iodide 
• 40530-18-5 5-bromo-2-hydroxybenzonitrile 
• 1452-94-4 ethyl 2-chloronicotinate 
• 1761-61-1 5-bromosalicyclaldehyde 
• 1033602-68-4 ethyl 2-(3-cyano-4-methoxymethoxyphenyl)nicotinate 
• 1033602-67-3 3-cyano-4-methoxymethoxyphenylboronic acid 
• 1033602-66-2 5-bromo-2-(methoxymethoxy)benzonitrile 
• 2942-59-8 2-chloronicotinic acid 

Downstream Products

• 1033601-47-6 2-(3-Cyano-4-methoxyphenyl)nicotinic acid 

Relevant academic research and scientific papers

2-PHENYLNICOTINIC ACID DERIVATIVE

The present invention is to provide the compounds useful as a treating or preventing agent for gout and hyperuricemia which are 2-phenylnicotinic acid derivatives having a uric acid lowering action due to an excellent xanthine oxidase inhibitory action. Since the 2-phenylnicotinic acid derivatives of the present invention exhibit a uric acid lowering action due to an excellent xanthine oxidase inhibitory action and also hypolipemic action, their utility is very high as a treating or preventive agent for gout and hyperuricemia which are often accompanied by hyperlipemia as a complication.